Promising Research: Lithium Orotate Reverses Alzheimer’s Symptoms in Mice

A recent breakthrough study from Harvard Medical School found that lithium orotate, a special form of lithium, reversed Alzheimer’s-like symptoms in mice. Unlike traditional lithium treatments, lithium orotate easily reaches brain cells without getting trapped in harmful amyloid plaques. Key findings: Lithium orotate reduced toxic amyloid plaques and tau tangles—hallmarks of Alzheimer’s. It restored memory and cognitive functions in the mice. The treatment worked at very low, safe doses, with no observed side effects. This form of lithium activates brain-protective genes and boosts neuron resilience. Why it matters for Parkinson’s disease: Lithium’s neuroprotective effects may also benefit PD by protecting dopamine neurons and reducing brain inflammation. The study supports ongoing interest in low-dose lithium as a safe, supportive therapy for neurodegenerative diseases. Important: This is an early animal study — more research and clinical trials are needed before applying these findings to humans. But it opens exciting possibilities for future treatments!